391 related articles for article (PubMed ID: 30204866)
1. Scaffold Proteins: From Coordinating Signaling Pathways to Metabolic Regulation.
Mugabo Y; Lim GE
Endocrinology; 2018 Nov; 159(11):3615-3630. PubMed ID: 30204866
[TBL] [Abstract][Full Text] [Related]
2. The Role of Adiponectin in Maintaining Metabolic Homeostasis.
Adiyaman SC; Ozer M; Saydam BO; Akinci B
Curr Diabetes Rev; 2020; 16(2):95-103. PubMed ID: 31267874
[TBL] [Abstract][Full Text] [Related]
3. Role of aquaglyceroporins and caveolins in energy and metabolic homeostasis.
Méndez-Giménez L; Rodríguez A; Balaguer I; Frühbeck G
Mol Cell Endocrinol; 2014 Nov; 397(1-2):78-92. PubMed ID: 25008241
[TBL] [Abstract][Full Text] [Related]
4. Brain insulin signalling in metabolic homeostasis and disease.
Scherer T; Sakamoto K; Buettner C
Nat Rev Endocrinol; 2021 Aug; 17(8):468-483. PubMed ID: 34108679
[TBL] [Abstract][Full Text] [Related]
5. Skeletal muscle and nuclear hormone receptors: implications for cardiovascular and metabolic disease.
Smith AG; Muscat GE
Int J Biochem Cell Biol; 2005 Oct; 37(10):2047-63. PubMed ID: 15922648
[TBL] [Abstract][Full Text] [Related]
6. Hepatokines and metabolism: Deciphering communication from the liver.
Jensen-Cody SO; Potthoff MJ
Mol Metab; 2021 Feb; 44():101138. PubMed ID: 33285302
[TBL] [Abstract][Full Text] [Related]
7. Glucose-Sensitive Myokine/Cardiokine MG53 Regulates Systemic Insulin Response and Metabolic Homeostasis.
Wu HK; Zhang Y; Cao CM; Hu X; Fang M; Yao Y; Jin L; Chen G; Jiang P; Zhang S; Song R; Peng W; Liu F; Guo J; Tang L; He Y; Shan D; Huang J; Zhou Z; Wang DW; Lv F; Xiao RP
Circulation; 2019 Feb; 139(7):901-914. PubMed ID: 30586741
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin in diabetes mellitus.
Xita N; Tsatsoulis A
Curr Med Chem; 2012; 19(32):5451-8. PubMed ID: 22876922
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor: effects on nutritional homeostasis, obesity and diabetes mellitus.
Viana Abranches M; Esteves de Oliveira FC; Bressan J
Nutr Hosp; 2011; 26(2):271-9. PubMed ID: 21666962
[TBL] [Abstract][Full Text] [Related]
10. Central nervous insulin resistance: a promising target in the treatment of metabolic and cognitive disorders?
Hallschmid M; Schultes B
Diabetologia; 2009 Nov; 52(11):2264-9. PubMed ID: 19705099
[TBL] [Abstract][Full Text] [Related]
11. Chemerin: a multifaceted adipokine involved in metabolic disorders.
Helfer G; Wu QF
J Endocrinol; 2018 Aug; 238(2):R79-R94. PubMed ID: 29848608
[TBL] [Abstract][Full Text] [Related]
12. Wingless-type inducible signaling pathway protein-1 (WISP1) adipokine and glucose homeostasis.
Yaribeygi H; Atkin SL; Sahebkar A
J Cell Physiol; 2019 Aug; 234(10):16966-16970. PubMed ID: 30807659
[TBL] [Abstract][Full Text] [Related]
13. Cystathionine γ-lyase deficiency aggravates obesity-related insulin resistance via FoxO1-dependent hepatic gluconeogenesis.
Guo W; Li D; You Y; Li W; Hu B; Zhang S; Miao L; Xian M; Zhu Y; Shen X
FASEB J; 2019 Mar; 33(3):4212-4224. PubMed ID: 30526049
[TBL] [Abstract][Full Text] [Related]
14. Insulin regulation of gluconeogenesis.
Hatting M; Tavares CDJ; Sharabi K; Rines AK; Puigserver P
Ann N Y Acad Sci; 2018 Jan; 1411(1):21-35. PubMed ID: 28868790
[TBL] [Abstract][Full Text] [Related]
15. ANGPTL8 (betatrophin) role in diabetes and metabolic diseases.
Abu-Farha M; Abubaker J; Tuomilehto J
Diabetes Metab Res Rev; 2017 Nov; 33(8):. PubMed ID: 28722798
[TBL] [Abstract][Full Text] [Related]
16. Glucose metabolism in obesity and type 2 diabetes.
Bonadonna RC; De Fronzo RA
Diabete Metab; 1991 May; 17(1 Pt 2):112-35. PubMed ID: 1936466
[TBL] [Abstract][Full Text] [Related]
17. Low density lipoprotein (LDL) receptor-related protein 6 (LRP6) regulates body fat and glucose homeostasis by modulating nutrient sensing pathways and mitochondrial energy expenditure.
Liu W; Singh R; Choi CS; Lee HY; Keramati AR; Samuel VT; Lifton RP; Shulman GI; Mani A
J Biol Chem; 2012 Mar; 287(10):7213-23. PubMed ID: 22232553
[TBL] [Abstract][Full Text] [Related]
18. Role of ω3 long-chain polyunsaturated fatty acids in reducing cardio-metabolic risk factors.
Abeywardena MY; Patten GS
Endocr Metab Immune Disord Drug Targets; 2011 Sep; 11(3):232-46. PubMed ID: 21831036
[TBL] [Abstract][Full Text] [Related]
19. The Role of Ceramides in Diabetes and Cardiovascular Disease Regulation of Ceramides by Adipokines.
Field BC; Gordillo R; Scherer PE
Front Endocrinol (Lausanne); 2020; 11():569250. PubMed ID: 33133017
[TBL] [Abstract][Full Text] [Related]
20. AMPK activators--potential therapeutics for metabolic and other diseases.
Zhou G; Sebhat IK; Zhang BB
Acta Physiol (Oxf); 2009 May; 196(1):175-90. PubMed ID: 19245659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
